Polymorphs of ethyl 3-[(2-{(4-(hexyloxycarbonylamino-imino methyl)phenylamino]methyl}-1-methyl-1 H-benzimidazole5-carbonyl)pyridin-2-ylamino)propionate

Details for Australian Patent Application No. 2006256778 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Hauel, Norbert; Sobotta, Rainer; Schmid, Rolf; Sieger, Peter

Agent Davies Collison Cave

Pub. Number AU-A-2006256778

PCT Pub. Number WO2006/131491

Priority 10 2005 025 728.3 04.06.05 DE

Filing date 1 June 2006

Wipo publication date 14 December 2006

International Classifications

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4184 (2006.01)

A61K 31/4402 (2006.01) - only substituted in position 2, e.g. pheniramine, bisacodyl

Event Publications

10 January 2008 PCT application entered the National Phase

  PCT publication WO2006/131491 Priority application(s): WO2006/131491

13 March 2008 Corrigenda

  PCT applications that have entered the National Phase - Name Index Under the name Boehringer Ingelheim International GmbH, Application No. 2006256778, Under INID (54), correct the title to Polymorphs of ethyl 3-[(2-{[4-(hexyloxycarbonylamino-iminomethyl)phenylamino]methyl}-1methyl-1H-benzimidazole-5-carbonyl)pyridin-2-ylamino]propionate

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006256783-HDAC regulation assays, compounds and therapeutic compositions

2006256771-Indole derivatives having antitumor activity